Skip to content
Tenfell
Cancelled
Published 19 Jan 2022

NHS National Generic Pharmaceuticals Wave 13

ATAMIS LTD

Key facts

Awarded
30 Nov 2021
Contract starts
01 Feb 2022
Contract ends
31 May 2024
Procedure
Open procedure (below threshold)
Buyer type
Other public body

Awarded to 50 suppliers

SupplierValue
FRESENIUS KABI LIMITED—
Baxter Healthcare Ltd—
Bowmed Ibisqus Limited—
Colonis Pharma Ltd—
Consilient Health Ltd—
Crescent Pharma Limited—
CST Pharma Ltd—
Dr Reddy's Laboratories (UK) Ltd—
GlaxoSmithKline—
Martindale Pharma—
Pfizer Ltd—
Ranbaxy (UK) Ltd—
Teva UK Ltd—
Bayer plc—
Aguettant Ltd—
Aventis Pharma Ltd T/A Sanofi—
B. Braun Medical Limited—
Ennogen Healthcare Ltd—
Napp Pharmaceuticals—
Rosemont Pharmaceuticals Ltd—
Sandoz Ltd—
Selective Supplies Ltd—
Thornton & Ross Ltd—
Wockhardt UK Limited—
Accord-UK Ltd—
Kent Pharma Ltd—
Merck Sharpe & Dohme (UK) Limited—
Mylan—
Neon Healthcare Ltd—
Organon Pharmaceuticals UK Ltd—
Roche Products Ltd—
Zentiva Pharma UK Ltd—
Amarox Limited—
Aristo Pharma Limited—
Brown & Burk UK Ltd—
Day Lewis Medical Ltd—
Drugsrus Ltd—
Fontus Health Ltd—
medac Pharma LLP—
Milpharm Ltd/aurobinbdo—
Relonchem Ltd—
Roma Pharmaceuticals Limited—
Syri Limited (T/A Thame Laboratories)—
Thea Pharmaceuticals Limited—
Glenmark Pharmaceuticals Europe Ltd—
Kyowa Kirin Limited—
Aspire Pharma Ltd—
Dr Falk Pharma UK Ltd—
Ferring Pharmaceuticals Limited—
LEO Pharma Ltd—

Description

Invitation to offer for NHS National Generic Pharmaceuticals Wave 13 Offer reference number: CM/PHG/17/5532 Period of framework agreement: The total maximum duration of the framework agreement to be no more than 28 months, with an option or options to extend (at the Authority's sole discretion) for a period or periods up to a total of 48 months.

Potential periods of call-offs under the framework agreement:

Transition (Everolimus) CESW: 1 March 2022 - 30 September 2023 (19 months) LSNE: 1 March 2022 - 31 January 2023 (11 months) NWLN: 1 March 2022 - 31 January 2023 (11 months)

Oral Products plus non-parenterals All Regions: 1 March 2022 - 31 May 2024 (27 months)

Hospital Only Products CESW: 1 February 2022 - 30 September 2023 (20 months) LSNE: 1 February 2022 - 31 May 2024 (28 months) NWLN: 1 February 2022 - 31 January 2023 (12 months)

Categories (CPV)

Similar open tenders

About ATAMIS LTD

Their tenders, awards, contracts coming up for renewal, decision makers and committee papers.

View buyer profile

Published by the buyer on Contracts Finder archive (Open Contracting) (Open Government Licence v3.0). Always read the original notice before responding.